Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-Cov-2 Infection: A New Risk Factor for Pituitary Apoplexy?
Ragni A, Bendotti G, Biamonte E, Cavigiolo B, Gabellieri E, Leporati P, Mollero ELM, Gallo M. Ragni A, et al. Among authors: gabellieri e. Endocr Metab Immune Disord Drug Targets. 2024 Apr 26. doi: 10.2174/0118715303315494240419060719. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38676521
Older Adults with Type 2 Diabetes Treated with Metformin: AME-MET Study - A Multicentric Real-world Study in Italy.
Elena C, Borretta G, Attanasio R, Alberto B, Agrimi D, Argese N, Crescenti C, Disoteo O, Fusco A, Gabellieri E, Guglielmi R, Lisco G, Lo Pomo F, Nizzoli M, Panico A, Pirali B, Salcuni AS, Turchi F, Grimaldi F. Elena C, et al. Among authors: gabellieri e. Endocr Metab Immune Disord Drug Targets. 2023;23(6):818-825. doi: 10.2174/1871530323666221115091621. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 36380441 Free PMC article.
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.
Candido R, Nicolucci A, Larosa M, Rossi MC, Napoli R; RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group. Candido R, et al. Nutr Metab Cardiovasc Dis. 2024 Mar 23:S0939-4753(24)00125-X. doi: 10.1016/j.numecd.2024.03.023. Online ahead of print. Nutr Metab Cardiovasc Dis. 2024. PMID: 38693036
Conjugation to gold nanoparticles of methionine gamma-lyase, a cancer-starving enzyme. Physicochemical characterization of the nanocomplex for prospective nanomedicine applications.
Raboni S, Fumagalli F, Ceccone G, La Spina R, Ponti J, Mehn D, Guerrini G, Bettati S, Mozzarelli A, D'Acunto M, Presciuttini G, Cristallini C, Gabellieri E, Cioni P. Raboni S, et al. Among authors: gabellieri e. Int J Pharm. 2024 Mar 25;653:123882. doi: 10.1016/j.ijpharm.2024.123882. Epub 2024 Feb 10. Int J Pharm. 2024. PMID: 38342324 Free article.
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study.
Candido R, Nicolucci A, Larosa M, Rossi MC, Napoli R; RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group. Candido R, et al. Nutr Metab Cardiovasc Dis. 2023 Nov;33(11):2294-2305. doi: 10.1016/j.numecd.2023.07.025. Epub 2023 Jul 22. Nutr Metab Cardiovasc Dis. 2023. PMID: 37679243 Free article.
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study.
Candido R, Modugno M, Larosa M, Rossi MC, Nicolucci A, Gabellieri E; ENSURE Study Group. Candido R, et al. Among authors: gabellieri e. Diabetes Ther. 2023 Jan;14(1):77-92. doi: 10.1007/s13300-022-01328-7. Epub 2022 Nov 14. Diabetes Ther. 2023. PMID: 36376644 Free PMC article.
Heat and cold denaturation of yeast frataxin: The effect of pressure.
Puglisi R, Cioni P, Gabellieri E, Presciuttini G, Pastore A, Temussi PA. Puglisi R, et al. Among authors: gabellieri e. Biophys J. 2022 Apr 19;121(8):1502-1511. doi: 10.1016/j.bpj.2022.03.010. Epub 2022 Mar 9. Biophys J. 2022. PMID: 35278425 Free PMC article.
A novel hotspot of gelsolin instability triggers an alternative mechanism of amyloid aggregation.
Bollati M, Diomede L, Giorgino T, Natale C, Fagnani E, Boniardi I, Barbiroli A, Alemani R, Beeg M, Gobbi M, Fakin A, Mastrangelo E, Milani M, Presciuttini G, Gabellieri E, Cioni P, de Rosa M. Bollati M, et al. Among authors: gabellieri e. Comput Struct Biotechnol J. 2021 Nov 19;19:6355-6365. doi: 10.1016/j.csbj.2021.11.025. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34938411 Free PMC article.
73 results